CLINICAL_TRIALS
trial_result
· 2015-01-16
Clinical Trial Update: A Safety Study of Oral ZSTK474 in Patients With Cancer [Phase 1]
Summary
Phase 1 safety study of oral ZSTK474 in patients with cancer has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Zenyaku Kogyo Co., Ltd. | Conditions: Neoplasms | Phase 1 | Status: COMPLETED